Gaucher disease type 3c: Expanding the clinical spectrum of an ultra-rare disease

IF 1.8 Q2 Biochemistry, Genetics and Molecular Biology
JIMD reports Pub Date : 2024-08-15 DOI:10.1002/jmd2.12440
John S. Wang, Rebecca L. Koch, Daniel Kenney-Jung, Erin Huggins, Sirajbir S. Sodhi, Andrew P. Landstrom, Dilraj S. Grewal, Priya S. Kishnani
{"title":"Gaucher disease type 3c: Expanding the clinical spectrum of an ultra-rare disease","authors":"John S. Wang,&nbsp;Rebecca L. Koch,&nbsp;Daniel Kenney-Jung,&nbsp;Erin Huggins,&nbsp;Sirajbir S. Sodhi,&nbsp;Andrew P. Landstrom,&nbsp;Dilraj S. Grewal,&nbsp;Priya S. Kishnani","doi":"10.1002/jmd2.12440","DOIUrl":null,"url":null,"abstract":"<p>Gaucher disease (GD) type 3 is an autosomal recessive lysosomal disease caused by deficiency of β-glucocerebrosidase (GCase) and encompasses a spectrum of cardiac, neurological, and ophthalmological abnormalities. Although the clinical presentations can be diverse, a recognized clinical trajectory points to an early onset, predominantly before 18 years. GD type 3c is primarily caused by homozygosity for <i>GBA</i> pathogenic variant c.1342G&gt;C (p.Asp448His; historically referred to as D409H) and includes visceral, hematological, skeletal, and cardiac abnormalities. Notably, GD type 3c is distinct from other GD types because it is primarily characterized by valvular heart disease. Yet, with less than 50 patients with GD type 3c reported to date, the phenotypic spectrum and extent of cardiac involvement remains ill-defined. We present a 20-year-old female with an atypical presentation of GD type 3c consisting of chronic intermediate uveitis as the presenting feature and the presence of extensive polyneuropathy starting in adolescence which has been previously unreported in GD type 3c. Distinctively, she has maintained normal cardiac function. Moreover, we compare our case with those reported in the literature to broaden awareness of the varied initial presentations of this disease. The diverse presentations seen in GD type 3c, underscored by our case and those previously reported, demonstrate the need for standardized evaluation and management protocols.</p>","PeriodicalId":14930,"journal":{"name":"JIMD reports","volume":"65 5","pages":"313-322"},"PeriodicalIF":1.8000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmd2.12440","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JIMD reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jmd2.12440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Gaucher disease (GD) type 3 is an autosomal recessive lysosomal disease caused by deficiency of β-glucocerebrosidase (GCase) and encompasses a spectrum of cardiac, neurological, and ophthalmological abnormalities. Although the clinical presentations can be diverse, a recognized clinical trajectory points to an early onset, predominantly before 18 years. GD type 3c is primarily caused by homozygosity for GBA pathogenic variant c.1342G>C (p.Asp448His; historically referred to as D409H) and includes visceral, hematological, skeletal, and cardiac abnormalities. Notably, GD type 3c is distinct from other GD types because it is primarily characterized by valvular heart disease. Yet, with less than 50 patients with GD type 3c reported to date, the phenotypic spectrum and extent of cardiac involvement remains ill-defined. We present a 20-year-old female with an atypical presentation of GD type 3c consisting of chronic intermediate uveitis as the presenting feature and the presence of extensive polyneuropathy starting in adolescence which has been previously unreported in GD type 3c. Distinctively, she has maintained normal cardiac function. Moreover, we compare our case with those reported in the literature to broaden awareness of the varied initial presentations of this disease. The diverse presentations seen in GD type 3c, underscored by our case and those previously reported, demonstrate the need for standardized evaluation and management protocols.

Abstract Image

戈谢病 3c 型:扩大超罕见疾病的临床范围
戈谢病(GD)3 型是一种常染色体隐性溶酶体疾病,由 β-葡糖脑苷脂酶(GCase)缺乏引起,包括一系列心脏、神经和眼科异常。虽然临床表现多种多样,但公认的临床轨迹表明,该病发病较早,主要发生在 18 岁之前。GD 3c 型主要由 GBA 致病变体 c.1342G>C(p.Asp448His;历史上称为 D409H)的同基因遗传引起,包括内脏、血液、骨骼和心脏异常。值得注意的是,GD 3c 型有别于其他 GD 型,因为它主要以瓣膜性心脏病为特征。然而,迄今只有不到 50 例 GD 3c 型患者被报道,其表型谱和心脏受累的程度仍不明确。我们为您介绍一名 20 岁女性 3c 型 GD 患者,她的非典型表现是以慢性中间葡萄膜炎为主要特征,并且从青春期开始出现广泛的多发性神经病变,这在以前的 3c 型 GD 患者中从未报道过。与众不同的是,她的心脏功能保持正常。此外,我们还将我们的病例与文献中报道的病例进行了比较,以扩大人们对这种疾病不同初始表现的认识。我们的病例和之前报道的病例都强调了 GD 3c 型的不同表现,这表明我们需要标准化的评估和管理方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JIMD reports
JIMD reports Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (miscellaneous)
CiteScore
3.30
自引率
0.00%
发文量
84
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信